Novel motif:163: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:26, 9 September 2013
name: | motif163_GARTCGCCCTGTNA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0010883 | regulation of lipid storage | 2.098496e-18 |
GO:0010888 | negative regulation of lipid storage | 8.598906e-14 |
GO:0001300 | chronological cell aging | 2.511071e-13 |
GO:0010743 | regulation of macrophage derived foam cell differentiation | 7.182626e-12 |
GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 1.427112e-10 |
GO:2000097 | regulation of smooth muscle cell-matrix adhesion | 1.257205e-9 |
GO:0046325 | negative regulation of glucose import | 3.511839e-9 |
GO:0045768 | positive regulation of anti-apoptosis | 5.755490e-9 |
GO:0070417 | cellular response to cold | 7.853407e-9 |
GO:0061043 | regulation of vascular wound healing | 9.080002e-9 |
GO:0035588 | G-protein coupled purinergic receptor signaling pathway | 1.365550e-8 |
GO:0061028 | establishment of endothelial barrier | 1.688381e-8 |
GO:2000098 | negative regulation of smooth muscle cell-matrix adhesion | 2.156336e-8 |
GO:0071258 | cellular response to gravity | 2.156336e-8 |
GO:0061044 | negative regulation of vascular wound healing | 2.156336e-8 |
GO:0035491 | positive regulation of leukotriene production involved in inflammatory response | 2.156336e-8 |
GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 3.255764e-8 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 3.357470e-8 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 4.893041e-8 |
GO:0071222 | cellular response to lipopolysaccharide | 5.900277e-8 |
GO:0045767 | regulation of anti-apoptosis | 1.035842e-7 |
GO:0071219 | cellular response to molecule of bacterial origin | 1.050145e-7 |
GO:0035587 | purinergic receptor signaling pathway | 1.159670e-7 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 2.007621e-7 |
GO:0010466 | negative regulation of peptidase activity | 2.920921e-7 |
GO:0032495 | response to muramyl dipeptide | 2.950545e-7 |
GO:0010884 | positive regulation of lipid storage | 3.355404e-7 |
GO:0060401 | cytosolic calcium ion transport | 3.708470e-7 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 3.991630e-7 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 4.152494e-7 |
GO:0071216 | cellular response to biotic stimulus | 8.240227e-7 |
GO:0032769 | negative regulation of monooxygenase activity | 8.367996e-7 |
GO:0032496 | response to lipopolysaccharide | 1.051001e-6 |
GO:0006767 | water-soluble vitamin metabolic process | 1.086466e-6 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 1.113591e-6 |
GO:0006222 | UMP biosynthetic process | 1.115052e-6 |
GO:0050852 | T cell receptor signaling pathway | 1.139699e-6 |
GO:0052547 | regulation of peptidase activity | 1.179395e-6 |
GO:0048791 | calcium ion-dependent exocytosis of neurotransmitter | 1.676836e-6 |
GO:0006916 | anti-apoptosis | 1.756098e-6 |
GO:0032494 | response to peptidoglycan | 1.804153e-6 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 1.822863e-6 |
GO:0048685 | negative regulation of collateral sprouting of intact axon in response to injury | 1.889898e-6 |
GO:0033629 | negative regulation of cell adhesion mediated by integrin | 1.924331e-6 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 1.979539e-6 |
GO:0009116 | nucleoside metabolic process | 2.460488e-6 |
GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 2.482518e-6 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 2.772920e-6 |
GO:0051707 | response to other organism | 2.946473e-6 |
GO:0042246 | tissue regeneration | 3.005885e-6 |
GO:0060027 | convergent extension involved in gastrulation | 3.197752e-6 |
GO:0050775 | positive regulation of dendrite morphogenesis | 3.265954e-6 |
GO:0051354 | negative regulation of oxidoreductase activity | 3.690916e-6 |
GO:0060928 | atrioventricular node cell development | 3.768840e-6 |
GO:0060929 | atrioventricular node cell fate commitment | 3.768840e-6 |
GO:0003342 | proepicardium development | 3.768840e-6 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 3.768840e-6 |
GO:0051904 | pigment granule transport | 3.951809e-6 |
GO:0032402 | melanosome transport | 4.097848e-6 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 4.107273e-6 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 4.155254e-6 |
GO:0007605 | sensory perception of sound | 4.568052e-6 |
GO:0002237 | response to molecule of bacterial origin | 4.905917e-6 |
GO:0022002 | negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway | 4.963322e-6 |
GO:0048263 | determination of dorsal identity | 4.963322e-6 |
GO:0055014 | atrial cardiac muscle cell development | 5.165691e-6 |
GO:0007286 | spermatid development | 6.046848e-6 |
GO:0031953 | negative regulation of protein autophosphorylation | 6.558535e-6 |
GO:0009607 | response to biotic stimulus | 6.631349e-6 |
GO:0051384 | response to glucocorticoid stimulus | 6.732722e-6 |
GO:0009615 | response to virus | 7.011873e-6 |
GO:0006213 | pyrimidine nucleoside metabolic process | 7.179464e-6 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 7.405071e-6 |
GO:0055093 | response to hyperoxia | 7.665710e-6 |
GO:0043900 | regulation of multi-organism process | 8.507733e-6 |
GO:0051877 | pigment granule aggregation in cell center | 8.703200e-6 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 9.804932e-6 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 9.928493e-6 |
GO:0042424 | catecholamine catabolic process | 1.026668e-5 |
GO:0003222 | ventricular trabecular myocardium morphogenesis | 1.065275e-5 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 1.065495e-5 |
GO:0051346 | negative regulation of hydrolase activity | 1.140031e-5 |
GO:0010038 | response to metal ion | 1.218568e-5 |
GO:0048515 | spermatid differentiation | 1.319561e-5 |
GO:0060402 | calcium ion transport into cytosol | 1.370798e-5 |
GO:0050851 | antigen receptor-mediated signaling pathway | 1.383245e-5 |
GO:0031960 | response to corticosteroid stimulus | 1.687377e-5 |
GO:0060556 | regulation of vitamin D biosynthetic process | 1.721844e-5 |
GO:0070874 | negative regulation of glycogen metabolic process | 1.742934e-5 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 1.750953e-5 |
GO:0051385 | response to mineralocorticoid stimulus | 1.771154e-5 |
GO:0033619 | membrane protein proteolysis | 1.855285e-5 |
GO:0051875 | pigment granule localization | 1.858915e-5 |
GO:0032102 | negative regulation of response to external stimulus | 1.865440e-5 |
GO:0050954 | sensory perception of mechanical stimulus | 1.925899e-5 |
GO:0016576 | histone dephosphorylation | 1.980267e-5 |
GO:0030538 | embryonic genitalia morphogenesis | 2.078673e-5 |
GO:0010886 | positive regulation of cholesterol storage | 2.115921e-5 |
GO:0032400 | melanosome localization | 2.124086e-5 |
GO:0060632 | regulation of microtubule-based movement | 2.167951e-5 |
GO:0001885 | endothelial cell development | 2.191261e-5 |
GO:0046847 | filopodium assembly | 2.230851e-5 |
GO:0061041 | regulation of wound healing | 2.313270e-5 |
GO:0006554 | lysine catabolic process | 2.377902e-5 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 2.416749e-5 |
GO:0060920 | pacemaker cell differentiation | 2.428866e-5 |
GO:0060971 | embryonic heart tube left/right pattern formation | 2.428866e-5 |
GO:0043973 | histone H3-K4 acetylation | 2.452503e-5 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 2.452503e-5 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 2.452503e-5 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 2.555308e-5 |
GO:0030035 | microspike assembly | 2.577704e-5 |
GO:0021756 | striatum development | 3.061410e-5 |
GO:0051282 | regulation of sequestering of calcium ion | 3.090416e-5 |
GO:0031284 | positive regulation of guanylate cyclase activity | 3.119611e-5 |
GO:0071674 | mononuclear cell migration | 3.119611e-5 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 3.137579e-5 |
GO:0051905 | establishment of pigment granule localization | 3.165640e-5 |
GO:0003278 | apoptosis involved in heart morphogenesis | 3.224443e-5 |
GO:0009726 | detection of endogenous stimulus | 3.228971e-5 |
GO:0050685 | positive regulation of mRNA processing | 3.411958e-5 |
GO:0032401 | establishment of melanosome localization | 3.556863e-5 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 3.671494e-5 |
GO:0019413 | acetate biosynthetic process | 3.745469e-5 |
GO:0019542 | propionate biosynthetic process | 3.745469e-5 |
GO:0002882 | positive regulation of chronic inflammatory response to non-antigenic stimulus | 4.054352e-5 |
GO:0051209 | release of sequestered calcium ion into cytosol | 4.078494e-5 |
GO:0021881 | Wnt receptor signaling pathway involved in forebrain neuron fate commitment | 4.107673e-5 |
GO:0030031 | cell projection assembly | 4.226315e-5 |
GO:0002253 | activation of immune response | 4.347704e-5 |
GO:0044205 | 'de novo' UMP biosynthetic process | 4.435126e-5 |
GO:0051900 | regulation of mitochondrial depolarization | 4.578128e-5 |
GO:0035058 | nonmotile primary cilium assembly | 4.585777e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 4.628974e-5 |
GO:0009629 | response to gravity | 4.640704e-5 |
GO:0061014 | positive regulation of mRNA catabolic process | 4.732438e-5 |
GO:0035590 | purinergic nucleotide receptor signaling pathway | 4.761951e-5 |
GO:0051591 | response to cAMP | 4.787222e-5 |
GO:0010713 | negative regulation of collagen metabolic process | 5.022733e-5 |
GO:0046951 | ketone body biosynthetic process | 5.407258e-5 |
GO:0010829 | negative regulation of glucose transport | 5.625697e-5 |
GO:0009617 | response to bacterium | 5.792991e-5 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 5.866910e-5 |
GO:0051656 | establishment of organelle localization | 6.357665e-5 |
GO:0003127 | detection of nodal flow | 6.762400e-5 |
GO:0009855 | determination of bilateral symmetry | 7.320006e-5 |
GO:0042976 | activation of Janus kinase activity | 7.607692e-5 |
GO:0032049 | cardiolipin biosynthetic process | 7.630849e-5 |
GO:0010044 | response to aluminum ion | 7.747820e-5 |
GO:0010033 | response to organic substance | 7.753848e-5 |
GO:0043627 | response to estrogen stimulus | 8.130414e-5 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 8.738021e-5 |
GO:0051704 | multi-organism process | 8.766203e-5 |
GO:0051258 | protein polymerization | 8.851154e-5 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 8.874556e-5 |
GO:0006509 | membrane protein ectodomain proteolysis | 9.241391e-5 |
GO:0006540 | glutamate decarboxylation to succinate | 9.561161e-5 |
GO:0030970 | retrograde protein transport, ER to cytosol | 9.740168e-5 |
GO:0032374 | regulation of cholesterol transport | 1.011994e-4 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 1.017324e-4 |
GO:0010288 | response to lead ion | 1.070319e-4 |
GO:0043086 | negative regulation of catalytic activity | 1.072614e-4 |
GO:0022009 | central nervous system vasculogenesis | 1.106447e-4 |
GO:0051902 | negative regulation of mitochondrial depolarization | 1.120902e-4 |
GO:0070483 | detection of hypoxia | 1.181249e-4 |
GO:0060585 | positive regulation of prostaglandin-endoperoxide synthase activity | 1.192031e-4 |
GO:0033059 | cellular pigmentation | 1.194878e-4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.202429e-4 |
GO:0050688 | regulation of defense response to virus | 1.227085e-4 |
GO:0046950 | cellular ketone body metabolic process | 1.269914e-4 |
GO:0021544 | subpallium development | 1.270540e-4 |
GO:0009799 | specification of symmetry | 1.294295e-4 |
GO:0032369 | negative regulation of lipid transport | 1.417802e-4 |
GO:0048262 | determination of dorsal/ventral asymmetry | 1.419049e-4 |
GO:0032606 | type I interferon production | 1.477292e-4 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.484894e-4 |
GO:0010875 | positive regulation of cholesterol efflux | 1.488177e-4 |
GO:0003254 | regulation of membrane depolarization | 1.488177e-4 |
GO:0001101 | response to acid | 1.595222e-4 |
GO:0071625 | vocalization behavior | 1.615059e-4 |
GO:0034135 | regulation of toll-like receptor 2 signaling pathway | 1.621789e-4 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.664611e-4 |
GO:0009296 | flagellum assembly | 1.694996e-4 |
GO:0032692 | negative regulation of interleukin-1 production | 1.788635e-4 |
GO:0042136 | neurotransmitter biosynthetic process | 1.816103e-4 |
GO:0048545 | response to steroid hormone stimulus | 1.831423e-4 |
GO:0009719 | response to endogenous stimulus | 1.833502e-4 |
GO:0045760 | positive regulation of action potential | 1.857716e-4 |
GO:0051568 | histone H3-K4 methylation | 1.896206e-4 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 1.938918e-4 |
GO:0042221 | response to chemical stimulus | 1.973528e-4 |
GO:0032368 | regulation of lipid transport | 1.977417e-4 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.998598e-4 |
GO:0006959 | humoral immune response | 2.046941e-4 |
GO:0002831 | regulation of response to biotic stimulus | 2.055095e-4 |
GO:0016339 | calcium-dependent cell-cell adhesion | 2.142857e-4 |
GO:0050668 | positive regulation of homocysteine metabolic process | 2.300467e-4 |
GO:0045963 | negative regulation of dopamine metabolic process | 2.300467e-4 |
GO:0016311 | dephosphorylation | 2.349384e-4 |
GO:0009119 | ribonucleoside metabolic process | 2.421074e-4 |
GO:0006517 | protein deglycosylation | 2.421998e-4 |
GO:0042981 | regulation of apoptosis | 2.457336e-4 |
GO:0009123 | nucleoside monophosphate metabolic process | 2.457623e-4 |
GO:0045909 | positive regulation of vasodilation | 2.493960e-4 |
GO:0014853 | regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction | 2.559925e-4 |
GO:0040007 | growth | 2.571881e-4 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 2.577602e-4 |
GO:0010885 | regulation of cholesterol storage | 2.633474e-4 |
GO:0033240 | positive regulation of cellular amine metabolic process | 2.644979e-4 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 2.700791e-4 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 2.738397e-4 |
GO:0042133 | neurotransmitter metabolic process | 2.770749e-4 |
GO:0051797 | regulation of hair follicle development | 2.806258e-4 |
GO:0046952 | ketone body catabolic process | 2.894220e-4 |
GO:0015755 | fructose transport | 2.967371e-4 |
GO:0014826 | vein smooth muscle contraction | 2.985042e-4 |
GO:0006940 | regulation of smooth muscle contraction | 3.049870e-4 |
GO:0014909 | smooth muscle cell migration | 3.068603e-4 |
GO:0016081 | synaptic vesicle docking involved in exocytosis | 3.081957e-4 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 3.083761e-4 |
GO:0032376 | positive regulation of cholesterol transport | 3.115736e-4 |
GO:0060841 | venous blood vessel development | 3.128621e-4 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 3.162291e-4 |
GO:0002536 | respiratory burst involved in inflammatory response | 3.234656e-4 |
GO:0051176 | positive regulation of sulfur metabolic process | 3.281699e-4 |
GO:0060972 | left/right pattern formation | 3.335240e-4 |
GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity | 3.335278e-4 |
GO:0048518 | positive regulation of biological process | 3.336154e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 3.412695e-4 |
GO:0052548 | regulation of endopeptidase activity | 3.490476e-4 |
GO:0046324 | regulation of glucose import | 3.572550e-4 |
GO:0022617 | extracellular matrix disassembly | 3.603427e-4 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 3.606804e-4 |
GO:0009068 | aspartate family amino acid catabolic process | 3.773917e-4 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 3.875610e-4 |
GO:0043375 | CD8-positive, alpha-beta T cell lineage commitment | 3.875610e-4 |
GO:0032848 | negative regulation of cellular pH reduction | 3.875610e-4 |
GO:0021747 | cochlear nucleus development | 3.875610e-4 |
GO:0010447 | response to acidity | 3.875610e-4 |
GO:0014042 | positive regulation of neuron maturation | 3.875610e-4 |
GO:0030212 | hyaluronan metabolic process | 3.918738e-4 |
GO:0002678 | positive regulation of chronic inflammatory response | 3.918738e-4 |
GO:0043067 | regulation of programmed cell death | 3.937409e-4 |
GO:0051051 | negative regulation of transport | 3.988294e-4 |
GO:0032691 | negative regulation of interleukin-1 beta production | 3.998650e-4 |
GO:0021570 | rhombomere 4 development | 4.004361e-4 |
GO:0006542 | glutamine biosynthetic process | 4.156540e-4 |
GO:0021546 | rhombomere development | 4.241878e-4 |
GO:0042762 | regulation of sulfur metabolic process | 4.327879e-4 |
GO:0003058 | hormonal regulation of the force of heart contraction | 4.351900e-4 |
GO:0060311 | negative regulation of elastin catabolic process | 4.429928e-4 |
GO:0010711 | negative regulation of collagen catabolic process | 4.429928e-4 |
GO:0060313 | negative regulation of blood vessel remodeling | 4.429928e-4 |
GO:0010703 | negative regulation of histolysis | 4.429928e-4 |
GO:0002765 | immune response-inhibiting signal transduction | 4.429928e-4 |
GO:0002826 | negative regulation of T-helper 1 type immune response | 4.438450e-4 |
GO:0007569 | cell aging | 4.452423e-4 |
GO:0042634 | regulation of hair cycle | 4.626359e-4 |
GO:0015993 | molecular hydrogen transport | 4.626851e-4 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 4.650036e-4 |
GO:0090310 | negative regulation of methylation-dependent chromatin silencing | 4.676723e-4 |
GO:0010889 | regulation of sequestering of triglyceride | 4.693691e-4 |
GO:0061013 | regulation of mRNA catabolic process | 4.810140e-4 |
GO:0035635 | entry of bacterium into host cell | 4.977400e-4 |
GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 4.977400e-4 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 4.977400e-4 |
GO:0003100 | regulation of systemic arterial blood pressure by endothelin | 5.025958e-4 |
GO:0097117 | guanylate kinase-associated protein clustering | 5.066742e-4 |
GO:0097114 | N-methyl-D-aspartate receptor clustering | 5.066742e-4 |
GO:0048683 | regulation of collateral sprouting of intact axon in response to injury | 5.066742e-4 |
GO:0097112 | gamma-aminobutyric acid receptor clustering | 5.066742e-4 |
GO:0050778 | positive regulation of immune response | 5.068181e-4 |
GO:0045471 | response to ethanol | 5.163649e-4 |
GO:0014824 | artery smooth muscle contraction | 5.172201e-4 |
GO:0010735 | positive regulation of transcription via serum response element binding | 5.214836e-4 |
GO:0000060 | protein import into nucleus, translocation | 5.310904e-4 |
GO:0043623 | cellular protein complex assembly | 5.392214e-4 |
GO:0030195 | negative regulation of blood coagulation | 5.407632e-4 |
GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 5.437739e-4 |
GO:0030643 | cellular phosphate ion homeostasis | 5.701675e-4 |
GO:0045638 | negative regulation of myeloid cell differentiation | 5.870190e-4 |
GO:0007157 | heterophilic cell-cell adhesion | 5.875366e-4 |
GO:0050666 | regulation of homocysteine metabolic process | 5.929838e-4 |
GO:0001808 | negative regulation of type IV hypersensitivity | 5.929838e-4 |
GO:0002684 | positive regulation of immune system process | 5.994495e-4 |
GO:0048012 | hepatocyte growth factor receptor signaling pathway | 6.069889e-4 |
GO:0070350 | regulation of white fat cell proliferation | 6.181490e-4 |
GO:0032101 | regulation of response to external stimulus | 6.278796e-4 |
GO:0070278 | extracellular matrix constituent secretion | 6.295822e-4 |
GO:0010260 | organ senescence | 6.295822e-4 |
GO:0051094 | positive regulation of developmental process | 6.389747e-4 |
GO:0051412 | response to corticosterone stimulus | 6.471627e-4 |
GO:0006808 | regulation of nitrogen utilization | 6.542555e-4 |
GO:0009310 | amine catabolic process | 6.557545e-4 |
GO:0008228 | opsonization | 6.573862e-4 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 6.573862e-4 |
GO:0048566 | embryonic digestive tract development | 6.576999e-4 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 6.608628e-4 |
GO:0045930 | negative regulation of mitotic cell cycle | 7.011579e-4 |
GO:0001973 | adenosine receptor signaling pathway | 7.209335e-4 |
GO:0031282 | regulation of guanylate cyclase activity | 7.259837e-4 |
GO:0032355 | response to estradiol stimulus | 7.278008e-4 |
GO:0051956 | negative regulation of amino acid transport | 7.284720e-4 |
GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 7.502455e-4 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 7.599550e-4 |
GO:0033688 | regulation of osteoblast proliferation | 7.690585e-4 |
GO:0008653 | lipopolysaccharide metabolic process | 7.690585e-4 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 7.734591e-4 |
GO:0001807 | regulation of type IV hypersensitivity | 7.780397e-4 |
GO:0007584 | response to nutrient | 7.823904e-4 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 8.056264e-4 |
GO:0032753 | positive regulation of interleukin-4 production | 8.140400e-4 |
GO:0009725 | response to hormone stimulus | 8.211389e-4 |
GO:0043064 | flagellum organization | 8.227811e-4 |
GO:0030505 | inorganic diphosphate transport | 8.240012e-4 |
GO:0000187 | activation of MAPK activity | 8.256005e-4 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 8.351760e-4 |
GO:0070904 | transepithelial L-ascorbic acid transport | 8.351760e-4 |
GO:0043570 | maintenance of DNA repeat elements | 8.584871e-4 |
GO:0002064 | epithelial cell development | 8.597332e-4 |
GO:0007174 | epidermal growth factor catabolic process | 8.643611e-4 |
GO:0007207 | activation of phospholipase C activity by muscarinic acetylcholine receptor signaling pathway | 8.677210e-4 |
GO:0009888 | tissue development | 8.757297e-4 |
GO:0048536 | spleen development | 8.844483e-4 |
GO:0044092 | negative regulation of molecular function | 8.864460e-4 |
GO:0050746 | regulation of lipoprotein metabolic process | 8.938594e-4 |
GO:0010744 | positive regulation of macrophage derived foam cell differentiation | 9.012912e-4 |
GO:0014912 | negative regulation of smooth muscle cell migration | 9.013214e-4 |
GO:0051953 | negative regulation of amine transport | 9.038327e-4 |
GO:0034371 | chylomicron remodeling | 9.256156e-4 |
GO:0042730 | fibrinolysis | 9.461334e-4 |
GO:0002326 | B cell lineage commitment | 9.490854e-4 |
GO:0045823 | positive regulation of heart contraction | 9.751012e-4 |
GO:0010243 | response to organic nitrogen | 9.913080e-4 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 9.917353e-4 |
GO:0006642 | triglyceride mobilization | 9.962507e-4 |
GO:0030193 | regulation of blood coagulation | 1.034995e-3 |
GO:0006457 | protein folding | 1.044637e-3 |
GO:0051648 | vesicle localization | 1.065126e-3 |
GO:2000347 | positive regulation of hepatocyte proliferation | 1.071384e-3 |
GO:2000349 | negative regulation of CD40 signaling pathway | 1.071384e-3 |
GO:0090291 | negative regulation of osteoclast proliferation | 1.071384e-3 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.071384e-3 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 1.071384e-3 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.071384e-3 |
GO:0072573 | tolerance induction to lipopolysaccharide | 1.071384e-3 |
GO:0042420 | dopamine catabolic process | 1.089912e-3 |
GO:0002688 | regulation of leukocyte chemotaxis | 1.093416e-3 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 1.096511e-3 |
GO:0071285 | cellular response to lithium ion | 1.101447e-3 |
GO:0090026 | positive regulation of monocyte chemotaxis | 1.109296e-3 |
GO:0042312 | regulation of vasodilation | 1.115540e-3 |
GO:0010035 | response to inorganic substance | 1.132281e-3 |
GO:0032891 | negative regulation of organic acid transport | 1.139880e-3 |
GO:0048857 | neural nucleus development | 1.140965e-3 |
GO:0045596 | negative regulation of cell differentiation | 1.145249e-3 |
GO:0043330 | response to exogenous dsRNA | 1.149889e-3 |
GO:0010874 | regulation of cholesterol efflux | 1.149889e-3 |
GO:0050690 | regulation of defense response to virus by virus | 1.157553e-3 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 1.192304e-3 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 1.200366e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 1.203804e-3 |
GO:0002462 | tolerance induction to nonself antigen | 1.203804e-3 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.204065e-3 |
GO:0050853 | B cell receptor signaling pathway | 1.214119e-3 |
GO:0051650 | establishment of vesicle localization | 1.232613e-3 |
GO:0070318 | positive regulation of G0 to G1 transition | 1.236823e-3 |
GO:0032879 | regulation of localization | 1.246491e-3 |
GO:0006508 | proteolysis | 1.247639e-3 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 1.272787e-3 |
GO:0006220 | pyrimidine nucleotide metabolic process | 1.281856e-3 |
GO:0007568 | aging | 1.311941e-3 |
GO:0002832 | negative regulation of response to biotic stimulus | 1.327808e-3 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 1.344458e-3 |
GO:0010941 | regulation of cell death | 1.358160e-3 |
GO:0071888 | macrophage apoptosis | 1.364160e-3 |
GO:0040023 | establishment of nucleus localization | 1.428014e-3 |
GO:0002764 | immune response-regulating signaling pathway | 1.435733e-3 |
GO:0009304 | tRNA transcription | 1.436556e-3 |
GO:0048845 | venous blood vessel morphogenesis | 1.437752e-3 |
GO:0014812 | muscle cell migration | 1.437752e-3 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 1.450274e-3 |
GO:0006538 | glutamate catabolic process | 1.469602e-3 |
GO:0031109 | microtubule polymerization or depolymerization | 1.473513e-3 |
GO:0014910 | regulation of smooth muscle cell migration | 1.477570e-3 |
GO:0042493 | response to drug | 1.487814e-3 |
GO:0007281 | germ cell development | 1.511997e-3 |
GO:0019220 | regulation of phosphate metabolic process | 1.557271e-3 |
GO:0042135 | neurotransmitter catabolic process | 1.561723e-3 |
GO:0070316 | regulation of G0 to G1 transition | 1.582115e-3 |
GO:0010890 | positive regulation of sequestering of triglyceride | 1.582115e-3 |
GO:0060137 | maternal process involved in parturition | 1.590342e-3 |
GO:0008219 | cell death | 1.611811e-3 |
GO:0050803 | regulation of synapse structure and activity | 1.616162e-3 |
GO:0071951 | conversion of methionyl-tRNA to N-formyl-methionyl-tRNA | 1.633338e-3 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 1.633825e-3 |
GO:0048619 | embryonic hindgut morphogenesis | 1.689398e-3 |
GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 1.742380e-3 |
GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity | 1.742380e-3 |
GO:0001504 | neurotransmitter uptake | 1.750976e-3 |
GO:0016265 | death | 1.768135e-3 |
GO:0016198 | axon choice point recognition | 1.777526e-3 |
GO:0042977 | activation of JAK2 kinase activity | 1.812427e-3 |
GO:0007368 | determination of left/right symmetry | 1.848701e-3 |
GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway | 1.870161e-3 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.887626e-3 |
GO:0034059 | response to anoxia | 1.902902e-3 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.934426e-3 |
GO:0006766 | vitamin metabolic process | 1.993892e-3 |
GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 1.999552e-3 |
GO:0045994 | positive regulation of translational initiation by iron | 2.006295e-3 |
GO:0002037 | negative regulation of L-glutamate transport | 2.006295e-3 |
GO:0050819 | negative regulation of coagulation | 2.021753e-3 |
GO:0006310 | DNA recombination | 2.036128e-3 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 2.050117e-3 |
GO:0042325 | regulation of phosphorylation | 2.063198e-3 |
GO:0046796 | viral genome transport in host cell | 2.065148e-3 |
GO:0051798 | positive regulation of hair follicle development | 2.102863e-3 |
GO:0021999 | neural plate anterior/posterior regionalization | 2.115936e-3 |
GO:0061036 | positive regulation of cartilage development | 2.148300e-3 |
GO:0050684 | regulation of mRNA processing | 2.176082e-3 |
GO:0045351 | type I interferon biosynthetic process | 2.216338e-3 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.216338e-3 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.216338e-3 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 2.226336e-3 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 2.238413e-3 |
GO:0048522 | positive regulation of cellular process | 2.251635e-3 |
GO:0034763 | negative regulation of transmembrane transport | 2.273612e-3 |
GO:0097118 | neuroligin clustering | 2.276567e-3 |
GO:0051341 | regulation of oxidoreductase activity | 2.296498e-3 |
GO:0045597 | positive regulation of cell differentiation | 2.303816e-3 |
GO:0019216 | regulation of lipid metabolic process | 2.309338e-3 |
GO:0080111 | DNA demethylation | 2.347730e-3 |
GO:0035729 | cellular response to hepatocyte growth factor stimulus | 2.347730e-3 |
GO:0071803 | positive regulation of podosome assembly | 2.351874e-3 |
GO:0032886 | regulation of microtubule-based process | 2.435888e-3 |
GO:0072321 | chaperone-mediated protein transport | 2.443493e-3 |
GO:0051293 | establishment of spindle localization | 2.448569e-3 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 2.483117e-3 |
GO:0002687 | positive regulation of leukocyte migration | 2.510115e-3 |
GO:0010701 | positive regulation of norepinephrine secretion | 2.571576e-3 |
GO:0001881 | receptor recycling | 2.571576e-3 |
GO:0043473 | pigmentation | 2.588139e-3 |
GO:0002757 | immune response-activating signal transduction | 2.605362e-3 |
GO:0042157 | lipoprotein metabolic process | 2.625216e-3 |
GO:0080134 | regulation of response to stress | 2.655198e-3 |
GO:0060999 | positive regulation of dendritic spine development | 2.664365e-3 |
GO:0060557 | positive regulation of vitamin D biosynthetic process | 2.668292e-3 |
GO:0034122 | negative regulation of toll-like receptor signaling pathway | 2.693301e-3 |
GO:0006915 | apoptosis | 2.695157e-3 |
GO:0032847 | regulation of cellular pH reduction | 2.706972e-3 |
GO:0010561 | negative regulation of glycoprotein biosynthetic process | 2.706972e-3 |
GO:0048585 | negative regulation of response to stimulus | 2.743858e-3 |
GO:0008628 | induction of apoptosis by hormones | 2.782908e-3 |
GO:0048016 | inositol phosphate-mediated signaling | 2.802161e-3 |
GO:0033574 | response to testosterone stimulus | 2.820390e-3 |
GO:0034104 | negative regulation of tissue remodeling | 2.828138e-3 |
GO:0032966 | negative regulation of collagen biosynthetic process | 2.835802e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 2.838849e-3 |
GO:0032754 | positive regulation of interleukin-5 production | 2.838849e-3 |
GO:2000739 | regulation of mesenchymal stem cell differentiation | 2.864664e-3 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 2.890495e-3 |
GO:2000348 | regulation of CD40 signaling pathway | 2.950190e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.950190e-3 |
GO:0018095 | protein polyglutamylation | 2.981594e-3 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 2.981594e-3 |
GO:0032703 | negative regulation of interleukin-2 production | 2.996067e-3 |
GO:0051093 | negative regulation of developmental process | 3.000550e-3 |
GO:0002676 | regulation of chronic inflammatory response | 3.005120e-3 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 3.005120e-3 |
GO:0001662 | behavioral fear response | 3.008170e-3 |
GO:0003285 | septum secundum development | 3.016364e-3 |
GO:0002669 | positive regulation of T cell anergy | 3.050670e-3 |
GO:0060911 | cardiac cell fate commitment | 3.050670e-3 |
GO:0021612 | facial nerve structural organization | 3.091237e-3 |
GO:0045646 | regulation of erythrocyte differentiation | 3.095863e-3 |
GO:0048589 | developmental growth | 3.112370e-3 |
GO:2000021 | regulation of ion homeostasis | 3.121786e-3 |
GO:0043368 | positive T cell selection | 3.158545e-3 |
GO:0070827 | chromatin maintenance | 3.170931e-3 |
GO:0035946 | mitochondrial mRNA surveillance | 3.170931e-3 |
GO:0035945 | mitochondrial ncRNA surveillance | 3.170931e-3 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 3.180321e-3 |
GO:0002360 | T cell lineage commitment | 3.182668e-3 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 3.200043e-3 |
GO:0032924 | activin receptor signaling pathway | 3.283393e-3 |
GO:0014821 | phasic smooth muscle contraction | 3.284934e-3 |
GO:0031532 | actin cytoskeleton reorganization | 3.293679e-3 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 3.318947e-3 |
GO:0012501 | programmed cell death | 3.349603e-3 |
GO:0010757 | negative regulation of plasminogen activation | 3.361748e-3 |
GO:0044254 | multicellular organismal protein catabolic process | 3.398095e-3 |
GO:0015891 | siderophore transport | 3.398095e-3 |
GO:0032375 | negative regulation of cholesterol transport | 3.469535e-3 |
GO:0030509 | BMP signaling pathway | 3.470947e-3 |
GO:0046685 | response to arsenic-containing substance | 3.492158e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 3.497529e-3 |
GO:0071391 | cellular response to estrogen stimulus | 3.533744e-3 |
GO:0015914 | phospholipid transport | 3.534197e-3 |
GO:0002682 | regulation of immune system process | 3.540074e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 2.874225e-16 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 1.588537e-14 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 3.937400e-13 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 3.937400e-13 |
GO:0060457 | negative regulation of digestive system process | 1.884222e-11 |
GO:0042116 | macrophage activation | 3.957262e-11 |
GO:0002579 | positive regulation of antigen processing and presentation | 9.015978e-11 |
GO:0002577 | regulation of antigen processing and presentation | 2.251892e-10 |
GO:0060008 | Sertoli cell differentiation | 1.379052e-9 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.864066e-9 |
GO:0015809 | arginine transport | 2.483611e-9 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 2.732852e-9 |
GO:0046058 | cAMP metabolic process | 3.525485e-9 |
GO:0043252 | sodium-independent organic anion transport | 3.627879e-9 |
GO:0060009 | Sertoli cell development | 4.267603e-9 |
GO:0072539 | T-helper 17 cell differentiation | 2.468452e-8 |
GO:0072521 | purine-containing compound metabolic process | 5.235791e-8 |
GO:0032680 | regulation of tumor necrosis factor production | 5.831112e-8 |
GO:0006163 | purine nucleotide metabolic process | 6.061354e-8 |
GO:0009187 | cyclic nucleotide metabolic process | 6.083760e-8 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 7.372938e-8 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 1.462357e-7 |
GO:0035752 | lysosomal lumen pH elevation | 1.978780e-7 |
GO:0001575 | globoside metabolic process | 1.978780e-7 |
GO:0000046 | autophagic vacuole fusion | 1.978780e-7 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 2.546777e-7 |
GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 3.178211e-7 |
GO:0045582 | positive regulation of T cell differentiation | 4.384055e-7 |
GO:0071361 | cellular response to ethanol | 5.730686e-7 |
GO:0060491 | regulation of cell projection assembly | 5.773812e-7 |
GO:0051489 | regulation of filopodium assembly | 5.946311e-7 |
GO:0002688 | regulation of leukocyte chemotaxis | 6.467703e-7 |
GO:0045919 | positive regulation of cytolysis | 6.646775e-7 |
GO:0051491 | positive regulation of filopodium assembly | 7.206193e-7 |
GO:0032743 | positive regulation of interleukin-2 production | 7.566982e-7 |
GO:0019374 | galactolipid metabolic process | 7.606491e-7 |
GO:0002675 | positive regulation of acute inflammatory response | 8.631987e-7 |
GO:0044058 | regulation of digestive system process | 9.429936e-7 |
GO:0044281 | small molecule metabolic process | 1.101931e-6 |
GO:0009117 | nucleotide metabolic process | 1.132925e-6 |
GO:0002699 | positive regulation of immune effector process | 1.208243e-6 |
GO:0002355 | detection of tumor cell | 1.413337e-6 |
GO:0002885 | positive regulation of hypersensitivity | 1.621011e-6 |
GO:0030595 | leukocyte chemotaxis | 1.683269e-6 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.704263e-6 |
GO:0045621 | positive regulation of lymphocyte differentiation | 1.734738e-6 |
GO:0015939 | pantothenate metabolic process | 1.819736e-6 |
GO:0030299 | intestinal cholesterol absorption | 1.920288e-6 |
GO:0051454 | intracellular pH elevation | 1.951850e-6 |
GO:0016242 | negative regulation of macroautophagy | 2.001805e-6 |
GO:0002347 | response to tumor cell | 2.001805e-6 |
GO:0015802 | basic amino acid transport | 2.058801e-6 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 2.144748e-6 |
GO:0031330 | negative regulation of cellular catabolic process | 2.187783e-6 |
GO:0002685 | regulation of leukocyte migration | 2.675936e-6 |
GO:0016241 | regulation of macroautophagy | 2.687826e-6 |
GO:0032760 | positive regulation of tumor necrosis factor production | 2.718760e-6 |
GO:0046700 | heterocycle catabolic process | 3.101020e-6 |
GO:0030593 | neutrophil chemotaxis | 3.113955e-6 |
GO:0042228 | interleukin-8 biosynthetic process | 4.694503e-6 |
GO:0033077 | T cell differentiation in thymus | 5.240616e-6 |
GO:0001817 | regulation of cytokine production | 5.821074e-6 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 6.082016e-6 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 6.082016e-6 |
GO:0002718 | regulation of cytokine production involved in immune response | 6.259600e-6 |
GO:0010165 | response to X-ray | 7.750381e-6 |
GO:0002821 | positive regulation of adaptive immune response | 8.000437e-6 |
GO:0006198 | cAMP catabolic process | 8.329223e-6 |
GO:0002922 | positive regulation of humoral immune response | 9.634851e-6 |
GO:0006681 | galactosylceramide metabolic process | 9.981664e-6 |
GO:0090174 | organelle membrane fusion | 1.016044e-5 |
GO:0042987 | amyloid precursor protein catabolic process | 1.033839e-5 |
GO:0045087 | innate immune response | 1.072854e-5 |
GO:0046483 | heterocycle metabolic process | 1.149050e-5 |
GO:0072523 | purine-containing compound catabolic process | 1.162121e-5 |
GO:0002863 | positive regulation of inflammatory response to antigenic stimulus | 1.296172e-5 |
GO:0045060 | negative thymic T cell selection | 1.334179e-5 |
GO:0044270 | cellular nitrogen compound catabolic process | 1.385038e-5 |
GO:0002726 | positive regulation of T cell cytokine production | 1.414289e-5 |
GO:0072610 | interleukin-12 secretion | 1.439547e-5 |
GO:0097022 | lymphocyte migration into lymph node | 1.439547e-5 |
GO:0050892 | intestinal absorption | 1.565145e-5 |
GO:0045820 | negative regulation of glycolysis | 1.583914e-5 |
GO:0006195 | purine nucleotide catabolic process | 1.654354e-5 |
GO:0009895 | negative regulation of catabolic process | 1.765136e-5 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 1.874172e-5 |
GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 1.887680e-5 |
GO:0032023 | trypsinogen activation | 1.977287e-5 |
GO:0009190 | cyclic nucleotide biosynthetic process | 1.997625e-5 |
GO:0097026 | dendritic cell dendrite assembly | 1.999057e-5 |
GO:0006438 | valyl-tRNA aminoacylation | 1.999057e-5 |
GO:0090022 | regulation of neutrophil chemotaxis | 2.018751e-5 |
GO:0030300 | regulation of intestinal cholesterol absorption | 2.140491e-5 |
GO:0006171 | cAMP biosynthetic process | 2.140491e-5 |
GO:0032642 | regulation of chemokine production | 2.148445e-5 |
GO:0007276 | gamete generation | 2.170855e-5 |
GO:0002281 | macrophage activation involved in immune response | 2.357946e-5 |
GO:0010758 | regulation of macrophage chemotaxis | 2.359975e-5 |
GO:0002883 | regulation of hypersensitivity | 2.359975e-5 |
GO:0071675 | regulation of mononuclear cell migration | 2.599230e-5 |
GO:2000107 | negative regulation of leukocyte apoptosis | 2.610176e-5 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 2.665843e-5 |
GO:0009166 | nucleotide catabolic process | 2.847202e-5 |
GO:0009259 | ribonucleotide metabolic process | 2.862430e-5 |
GO:0009150 | purine ribonucleotide metabolic process | 2.902878e-5 |
GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 2.963223e-5 |
GO:0071403 | cellular response to high density lipoprotein particle stimulus | 3.325931e-5 |
GO:0071448 | cellular response to alkyl hydroperoxide | 3.325931e-5 |
GO:0071315 | cellular response to morphine | 3.325931e-5 |
GO:0050904 | diapedesis | 3.325931e-5 |
GO:0071307 | cellular response to vitamin K | 3.325931e-5 |
GO:0031269 | pseudopodium assembly | 3.325931e-5 |
GO:0045123 | cellular extravasation | 3.451329e-5 |
GO:0009303 | rRNA transcription | 3.451329e-5 |
GO:0001819 | positive regulation of cytokine production | 3.545110e-5 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 3.632528e-5 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 3.799007e-5 |
GO:0010212 | response to ionizing radiation | 4.103041e-5 |
GO:0045624 | positive regulation of T-helper cell differentiation | 4.143083e-5 |
GO:0072676 | lymphocyte migration | 4.615677e-5 |
GO:0002673 | regulation of acute inflammatory response | 4.709082e-5 |
GO:0010888 | negative regulation of lipid storage | 4.881521e-5 |
GO:0045622 | regulation of T-helper cell differentiation | 5.340942e-5 |
GO:0002274 | myeloid leukocyte activation | 5.515216e-5 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 5.665365e-5 |
GO:0006643 | membrane lipid metabolic process | 5.831334e-5 |
GO:0009125 | nucleoside monophosphate catabolic process | 6.202289e-5 |
GO:0001516 | prostaglandin biosynthetic process | 6.302070e-5 |
GO:0048247 | lymphocyte chemotaxis | 6.586544e-5 |
GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 6.926178e-5 |
GO:0046034 | ATP metabolic process | 7.519460e-5 |
GO:0006678 | glucosylceramide metabolic process | 7.674040e-5 |
GO:0034655 | nucleobase-containing compound catabolic process | 7.735641e-5 |
GO:0031427 | response to methotrexate | 8.125424e-5 |
GO:0006360 | transcription from RNA polymerase I promoter | 8.520796e-5 |
GO:0035026 | leading edge cell differentiation | 8.737840e-5 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 9.117290e-5 |
GO:0072522 | purine-containing compound biosynthetic process | 9.397206e-5 |
GO:0001774 | microglial cell activation | 9.727547e-5 |
GO:0050775 | positive regulation of dendrite morphogenesis | 9.853929e-5 |
GO:0006955 | immune response | 1.023886e-4 |
GO:0002518 | lymphocyte chemotaxis across high endothelial venule | 1.034832e-4 |
GO:2000412 | positive regulation of thymocyte migration | 1.034832e-4 |
GO:0046637 | regulation of alpha-beta T cell differentiation | 1.038699e-4 |
GO:0001959 | regulation of cytokine-mediated signaling pathway | 1.047849e-4 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 1.057564e-4 |
GO:0016485 | protein processing | 1.110519e-4 |
GO:0043383 | negative T cell selection | 1.116353e-4 |
GO:0032908 | regulation of transforming growth factor beta1 production | 1.217318e-4 |
GO:0010898 | positive regulation of triglyceride catabolic process | 1.217318e-4 |
GO:0002830 | positive regulation of type 2 immune response | 1.231117e-4 |
GO:0002649 | regulation of tolerance induction to self antigen | 1.269227e-4 |
GO:0050778 | positive regulation of immune response | 1.298336e-4 |
GO:0072659 | protein localization in plasma membrane | 1.298992e-4 |
GO:0032418 | lysosome localization | 1.304132e-4 |
GO:0010759 | positive regulation of macrophage chemotaxis | 1.324412e-4 |
GO:0060759 | regulation of response to cytokine stimulus | 1.334792e-4 |
GO:0007052 | mitotic spindle organization | 1.351419e-4 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.356698e-4 |
GO:0010935 | regulation of macrophage cytokine production | 1.359947e-4 |
GO:0044241 | lipid digestion | 1.366245e-4 |
GO:0048034 | heme O biosynthetic process | 1.376708e-4 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 1.376708e-4 |
GO:0006693 | prostaglandin metabolic process | 1.425281e-4 |
GO:0045061 | thymic T cell selection | 1.432124e-4 |
GO:0080135 | regulation of cellular response to stress | 1.438597e-4 |
GO:0050900 | leukocyte migration | 1.445057e-4 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.455568e-4 |
GO:0043091 | L-arginine import | 1.456630e-4 |
GO:0045342 | MHC class II biosynthetic process | 1.456630e-4 |
GO:0060929 | atrioventricular node cell fate commitment | 1.456630e-4 |
GO:0070839 | divalent metal ion export | 1.456630e-4 |
GO:0060928 | atrioventricular node cell development | 1.456630e-4 |
GO:0035470 | positive regulation of vascular wound healing | 1.456630e-4 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 1.456630e-4 |
GO:0001923 | B-1 B cell differentiation | 1.456630e-4 |
GO:0032632 | interleukin-3 production | 1.456630e-4 |
GO:0003342 | proepicardium development | 1.456630e-4 |
GO:0006876 | cellular cadmium ion homeostasis | 1.456630e-4 |
GO:0015707 | nitrite transport | 1.456630e-4 |
GO:0009595 | detection of biotic stimulus | 1.471090e-4 |
GO:0007252 | I-kappaB phosphorylation | 1.506111e-4 |
GO:0051365 | cellular response to potassium ion starvation | 1.572169e-4 |
GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 1.572169e-4 |
GO:0050921 | positive regulation of chemotaxis | 1.595555e-4 |
GO:0033233 | regulation of protein sumoylation | 1.612238e-4 |
GO:0002687 | positive regulation of leukocyte migration | 1.642876e-4 |
GO:0050920 | regulation of chemotaxis | 1.648901e-4 |
GO:0002230 | positive regulation of defense response to virus by host | 1.666909e-4 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 1.764845e-4 |
GO:0000187 | activation of MAPK activity | 1.883320e-4 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 1.954189e-4 |
GO:0009141 | nucleoside triphosphate metabolic process | 1.975035e-4 |
GO:0060326 | cell chemotaxis | 2.061547e-4 |
GO:0006665 | sphingolipid metabolic process | 2.126907e-4 |
GO:0019953 | sexual reproduction | 2.189778e-4 |
GO:0045619 | regulation of lymphocyte differentiation | 2.233688e-4 |
GO:0009214 | cyclic nucleotide catabolic process | 2.237698e-4 |
GO:0006164 | purine nucleotide biosynthetic process | 2.256873e-4 |
GO:0070684 | seminal clot liquefaction | 2.340675e-4 |
GO:0061338 | atrioventricular node impulse conduction delay | 2.454136e-4 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 2.467433e-4 |
GO:0010933 | positive regulation of macrophage tolerance induction | 2.540184e-4 |
GO:0071671 | regulation of smooth muscle cell chemotaxis | 2.651116e-4 |
GO:0031638 | zymogen activation | 2.700903e-4 |
GO:0010832 | negative regulation of myotube differentiation | 2.700903e-4 |
GO:0002697 | regulation of immune effector process | 2.734067e-4 |
GO:0010591 | regulation of lamellipodium assembly | 2.849209e-4 |
GO:0045580 | regulation of T cell differentiation | 2.896067e-4 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 2.910420e-4 |
GO:0071453 | cellular response to oxygen levels | 2.948318e-4 |
GO:0042268 | regulation of cytolysis | 3.003790e-4 |
GO:0001556 | oocyte maturation | 3.087646e-4 |
GO:0002684 | positive regulation of immune system process | 3.191657e-4 |
GO:0002906 | negative regulation of mature B cell apoptosis | 3.247400e-4 |
GO:0002828 | regulation of type 2 immune response | 3.275472e-4 |
GO:0001986 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure | 3.372789e-4 |
GO:0002643 | regulation of tolerance induction | 3.372937e-4 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 3.556203e-4 |
GO:0071447 | cellular response to hydroperoxide | 3.628169e-4 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 3.698381e-4 |
GO:0048627 | myoblast development | 3.855803e-4 |
GO:0007250 | activation of NF-kappaB-inducing kinase activity | 3.906831e-4 |
GO:0010830 | regulation of myotube differentiation | 3.925320e-4 |
GO:0033604 | negative regulation of catecholamine secretion | 3.933891e-4 |
GO:0051604 | protein maturation | 4.011785e-4 |
GO:0016310 | phosphorylation | 4.087173e-4 |
GO:2000001 | regulation of DNA damage checkpoint | 4.101820e-4 |
GO:0031268 | pseudopodium organization | 4.101820e-4 |
GO:0048477 | oogenesis | 4.121274e-4 |
GO:0042990 | regulation of transcription factor import into nucleus | 4.273372e-4 |
GO:0002861 | regulation of inflammatory response to antigenic stimulus | 4.310699e-4 |
GO:0071635 | negative regulation of transforming growth factor beta production | 4.430989e-4 |
GO:0042982 | amyloid precursor protein metabolic process | 4.636629e-4 |
GO:0001768 | establishment of T cell polarity | 4.637486e-4 |
GO:0034695 | response to prostaglandin E stimulus | 4.911156e-4 |
GO:0016075 | rRNA catabolic process | 5.187029e-4 |
GO:0010700 | negative regulation of norepinephrine secretion | 5.187029e-4 |
GO:0002724 | regulation of T cell cytokine production | 5.255334e-4 |
GO:0002418 | immune response to tumor cell | 5.680016e-4 |
GO:0000966 | RNA 5'-end processing | 5.680016e-4 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 5.817566e-4 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 5.845367e-4 |
GO:0007281 | germ cell development | 5.950423e-4 |
GO:0002309 | T cell proliferation involved in immune response | 5.956952e-4 |
GO:0045627 | positive regulation of T-helper 1 cell differentiation | 5.966274e-4 |
GO:0046634 | regulation of alpha-beta T cell activation | 5.987488e-4 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 6.113664e-4 |
GO:0006664 | glycolipid metabolic process | 6.128522e-4 |
GO:0032615 | interleukin-12 production | 6.144392e-4 |
GO:0002407 | dendritic cell chemotaxis | 6.144392e-4 |
GO:0030203 | glycosaminoglycan metabolic process | 6.246399e-4 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 6.502002e-4 |
GO:0045058 | T cell selection | 6.685225e-4 |
GO:0001920 | negative regulation of receptor recycling | 6.785824e-4 |
GO:0003222 | ventricular trabecular myocardium morphogenesis | 6.849851e-4 |
GO:0032736 | positive regulation of interleukin-13 production | 6.885963e-4 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 6.885963e-4 |
GO:0010891 | negative regulation of sequestering of triglyceride | 6.885963e-4 |
GO:0006690 | icosanoid metabolic process | 7.250042e-4 |
GO:0009154 | purine ribonucleotide catabolic process | 7.392333e-4 |
GO:0006796 | phosphate-containing compound metabolic process | 7.403203e-4 |
GO:0043525 | positive regulation of neuron apoptosis | 7.598615e-4 |
GO:0010592 | positive regulation of lamellipodium assembly | 7.653723e-4 |
GO:0043249 | erythrocyte maturation | 7.653723e-4 |
GO:0009261 | ribonucleotide catabolic process | 7.873248e-4 |
GO:0032722 | positive regulation of chemokine production | 8.047205e-4 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 8.078245e-4 |
GO:0061337 | cardiac conduction | 8.278929e-4 |
GO:0050776 | regulation of immune response | 8.485507e-4 |
GO:0032103 | positive regulation of response to external stimulus | 8.522423e-4 |
GO:0032847 | regulation of cellular pH reduction | 8.529228e-4 |
GO:0001544 | initiation of primordial ovarian follicle growth | 8.756504e-4 |
GO:0051725 | protein de-ADP-ribosylation | 9.077091e-4 |
GO:0000073 | spindle pole body separation | 9.077091e-4 |
GO:0009165 | nucleotide biosynthetic process | 9.083125e-4 |
GO:0051930 | regulation of sensory perception of pain | 9.480380e-4 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 9.668106e-4 |
GO:0042177 | negative regulation of protein catabolic process | 9.843442e-4 |
GO:0002286 | T cell activation involved in immune response | 9.971149e-4 |
GO:0071622 | regulation of granulocyte chemotaxis | 9.977281e-4 |
GO:0015914 | phospholipid transport | 1.007502e-3 |
GO:0050996 | positive regulation of lipid catabolic process | 1.009632e-3 |
GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1.012839e-3 |
GO:0010889 | regulation of sequestering of triglyceride | 1.025818e-3 |
GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity | 1.032557e-3 |
GO:0002070 | epithelial cell maturation | 1.032557e-3 |
GO:0042246 | tissue regeneration | 1.044933e-3 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 1.050405e-3 |
GO:0002825 | regulation of T-helper 1 type immune response | 1.066705e-3 |
GO:0018130 | heterocycle biosynthetic process | 1.080312e-3 |
GO:0010430 | fatty acid omega-oxidation | 1.102744e-3 |
GO:0002357 | defense response to tumor cell | 1.102744e-3 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 1.108306e-3 |
GO:0034340 | response to type I interferon | 1.112333e-3 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 1.112333e-3 |
GO:0003417 | growth plate cartilage development | 1.113453e-3 |
GO:2000401 | regulation of lymphocyte migration | 1.127212e-3 |
GO:0002764 | immune response-regulating signaling pathway | 1.145595e-3 |
GO:0071347 | cellular response to interleukin-1 | 1.151355e-3 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 1.167987e-3 |
GO:0043406 | positive regulation of MAP kinase activity | 1.184824e-3 |
GO:0071731 | response to nitric oxide | 1.188659e-3 |
GO:0071504 | cellular response to heparin | 1.192195e-3 |
GO:0006756 | AMP phosphorylation | 1.270484e-3 |
GO:0090208 | positive regulation of triglyceride metabolic process | 1.273833e-3 |
GO:0055117 | regulation of cardiac muscle contraction | 1.301086e-3 |
GO:0030204 | chondroitin sulfate metabolic process | 1.313042e-3 |
GO:0032849 | positive regulation of cellular pH reduction | 1.322633e-3 |
GO:0002757 | immune response-activating signal transduction | 1.326614e-3 |
GO:0055099 | response to high density lipoprotein particle stimulus | 1.364435e-3 |
GO:0002376 | immune system process | 1.374493e-3 |
GO:0046958 | nonassociative learning | 1.393250e-3 |
GO:0015886 | heme transport | 1.393250e-3 |
GO:0000165 | MAPKKK cascade | 1.408398e-3 |
GO:0032108 | negative regulation of response to nutrient levels | 1.414365e-3 |
GO:0050795 | regulation of behavior | 1.434392e-3 |
GO:0080134 | regulation of response to stress | 1.444690e-3 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1.446467e-3 |
GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 1.459538e-3 |
GO:0046037 | GMP metabolic process | 1.472481e-3 |
GO:0043519 | regulation of myosin II filament organization | 1.472481e-3 |
GO:0071503 | response to heparin | 1.473462e-3 |
GO:0042098 | T cell proliferation | 1.488692e-3 |
GO:0045059 | positive thymic T cell selection | 1.519741e-3 |
GO:0097117 | guanylate kinase-associated protein clustering | 1.520167e-3 |
GO:0097114 | N-methyl-D-aspartate receptor clustering | 1.520167e-3 |
GO:0015670 | carbon dioxide transport | 1.520167e-3 |
GO:0097112 | gamma-aminobutyric acid receptor clustering | 1.520167e-3 |
GO:0051545 | negative regulation of elastin biosynthetic process | 1.537863e-3 |
GO:0006952 | defense response | 1.570258e-3 |
GO:0050853 | B cell receptor signaling pathway | 1.572937e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.615916e-3 |
GO:0010896 | regulation of triglyceride catabolic process | 1.623295e-3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.644808e-3 |
GO:0046456 | icosanoid biosynthetic process | 1.649111e-3 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1.650614e-3 |
GO:0048609 | multicellular organismal reproductive process | 1.713133e-3 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 1.723609e-3 |
GO:2000110 | negative regulation of macrophage apoptosis | 1.723609e-3 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 1.723609e-3 |
GO:0006433 | prolyl-tRNA aminoacylation | 1.723609e-3 |
GO:0032203 | telomere formation via telomerase | 1.723609e-3 |
GO:0060971 | embryonic heart tube left/right pattern formation | 1.723609e-3 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 1.739931e-3 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.758055e-3 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 1.762828e-3 |
GO:0051929 | positive regulation of calcium ion transport via voltage-gated calcium channel activity | 1.805687e-3 |
GO:0006200 | ATP catabolic process | 1.835832e-3 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 1.861640e-3 |
GO:0032902 | nerve growth factor production | 1.894015e-3 |
GO:0050766 | positive regulation of phagocytosis | 1.912945e-3 |
GO:0009143 | nucleoside triphosphate catabolic process | 1.919180e-3 |
GO:0006022 | aminoglycan metabolic process | 1.945818e-3 |
GO:0002920 | regulation of humoral immune response | 1.959964e-3 |
GO:0006468 | protein phosphorylation | 1.984042e-3 |
GO:0032754 | positive regulation of interleukin-5 production | 1.992879e-3 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 1.995084e-3 |
GO:0051453 | regulation of intracellular pH | 2.024553e-3 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 2.024669e-3 |
GO:0002224 | toll-like receptor signaling pathway | 2.070530e-3 |
GO:0071267 | L-methionine salvage | 2.106830e-3 |
GO:0032101 | regulation of response to external stimulus | 2.184491e-3 |
GO:0090303 | positive regulation of wound healing | 2.210814e-3 |
GO:0007283 | spermatogenesis | 2.268990e-3 |
GO:0046940 | nucleoside monophosphate phosphorylation | 2.277713e-3 |
GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.277713e-3 |
GO:0003278 | apoptosis involved in heart morphogenesis | 2.277713e-3 |
GO:0007028 | cytoplasm organization | 2.310300e-3 |
GO:0051607 | defense response to virus | 2.459182e-3 |
GO:0070932 | histone H3 deacetylation | 2.549218e-3 |
GO:0071456 | cellular response to hypoxia | 2.552027e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 2.556949e-3 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 2.589780e-3 |
GO:0002819 | regulation of adaptive immune response | 2.593797e-3 |
GO:0006516 | glycoprotein catabolic process | 2.609420e-3 |
GO:0048537 | mucosal-associated lymphoid tissue development | 2.609420e-3 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 2.634198e-3 |
GO:0048610 | cellular process involved in reproduction | 2.661467e-3 |
GO:0003416 | endochondral bone growth | 2.783622e-3 |
GO:0060760 | positive regulation of response to cytokine stimulus | 2.816723e-3 |
GO:0070229 | negative regulation of lymphocyte apoptosis | 2.892260e-3 |
GO:0034661 | ncRNA catabolic process | 2.901787e-3 |
GO:0032107 | regulation of response to nutrient levels | 2.930066e-3 |
GO:0021570 | rhombomere 4 development | 2.943199e-3 |
GO:0016554 | cytidine to uridine editing | 2.962171e-3 |
GO:0051452 | intracellular pH reduction | 3.033566e-3 |
GO:0060676 | ureteric bud formation | 3.037373e-3 |
GO:0051639 | actin filament network formation | 3.055233e-3 |
GO:0045343 | regulation of MHC class I biosynthetic process | 3.055233e-3 |
GO:0032571 | response to vitamin K | 3.055233e-3 |
GO:0006937 | regulation of muscle contraction | 3.100924e-3 |
GO:0032374 | regulation of cholesterol transport | 3.108604e-3 |
GO:0006687 | glycosphingolipid metabolic process | 3.134127e-3 |
GO:0060907 | positive regulation of macrophage cytokine production | 3.143773e-3 |
GO:0007042 | lysosomal lumen acidification | 3.231396e-3 |
GO:0001816 | cytokine production | 3.236611e-3 |
GO:0002686 | negative regulation of leukocyte migration | 3.263620e-3 |
GO:0045823 | positive regulation of heart contraction | 3.308472e-3 |
GO:0045861 | negative regulation of proteolysis | 3.366829e-3 |
GO:0045625 | regulation of T-helper 1 cell differentiation | 3.464783e-3 |
GO:0018149 | peptide cross-linking | 3.565482e-3 |
GO:0010507 | negative regulation of autophagy | 3.577924e-3 |
GO:0002711 | positive regulation of T cell mediated immunity | 3.613945e-3 |
GO:0019276 | UDP-N-acetylgalactosamine metabolic process | 3.629817e-3 |
GO:0006784 | heme a biosynthetic process | 3.629817e-3 |
GO:0007127 | meiosis I | 3.639724e-3 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 3.683366e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 3.730158e-3 |
GO:0008582 | regulation of synaptic growth at neuromuscular junction | 3.730158e-3 |
GO:0007144 | female meiosis I | 3.730158e-3 |
GO:0032880 | regulation of protein localization | 3.732498e-3 |
GO:0010820 | positive regulation of T cell chemotaxis | 3.765645e-3 |
GO:0006477 | protein sulfation | 3.776672e-3 |
GO:0060754 | positive regulation of mast cell chemotaxis | 3.837112e-3 |
GO:0016045 | detection of bacterium | 3.837112e-3 |
GO:0002051 | osteoblast fate commitment | 3.837112e-3 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 3.845943e-3 |
GO:0007530 | sex determination | 3.861920e-3 |
GO:0001974 | blood vessel remodeling | 4.011628e-3 |
GO:2000406 | positive regulation of T cell migration | 4.038784e-3 |
GO:0050663 | cytokine secretion | 4.089915e-3 |
GO:0048599 | oocyte development | 4.091829e-3 |
GO:0051209 | release of sequestered calcium ion into cytosol | 4.133313e-3 |
GO:0007193 | inhibition of adenylate cyclase activity by G-protein signaling pathway | 4.133698e-3 |
GO:0072657 | protein localization in membrane | 4.149339e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 4.150320e-3 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 4.150320e-3 |
GO:0046086 | adenosine biosynthetic process | 4.238097e-3 |
GO:0006196 | AMP catabolic process | 4.238097e-3 |
GO:0046640 | regulation of alpha-beta T cell proliferation | 4.251602e-3 |
GO:0060010 | Sertoli cell fate commitment | 4.277898e-3 |
GO:0051127 | positive regulation of actin nucleation | 4.277898e-3 |
GO:0050994 | regulation of lipid catabolic process | 4.390917e-3 |
GO:0043410 | positive regulation of MAPKKK cascade | 4.406716e-3 |
GO:0007588 | excretion | 4.455286e-3 |
GO:0008052 | sensory organ boundary specification | 4.493012e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 4.493012e-3 |
GO:0007402 | ganglion mother cell fate determination | 4.493012e-3 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 4.510537e-3 |
GO:0048535 | lymph node development | 4.523507e-3 |
GO:0010559 | regulation of glycoprotein biosynthetic process | 4.628592e-3 |
GO:0007035 | vacuolar acidification | 4.648301e-3 |
GO:2001020 | regulation of response to DNA damage stimulus | 4.737932e-3 |
GO:0002700 | regulation of production of molecular mediator of immune response | 4.824928e-3 |
GO:0031054 | pre-miRNA processing | 4.845600e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 4.939413e-3 |
GO:0030252 | growth hormone secretion | 5.003665e-3 |
GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 5.015592e-3 |
GO:0070201 | regulation of establishment of protein localization | 5.029634e-3 |
GO:0046328 | regulation of JNK cascade | 5.046605e-3 |
GO:0018298 | protein-chromophore linkage | 5.069692e-3 |
GO:0033194 | response to hydroperoxide | 5.251889e-3 |
GO:0032102 | negative regulation of response to external stimulus | 5.374988e-3 |
GO:0006029 | proteoglycan metabolic process | 5.439302e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 5.562466e-3 |
GO:0007184 | SMAD protein import into nucleus | 5.579881e-3 |
GO:0042093 | T-helper cell differentiation | 5.650036e-3 |
GO:0043331 | response to dsRNA | 5.697698e-3 |
GO:0051615 | histamine uptake | 5.706893e-3 |
GO:0034112 | positive regulation of homotypic cell-cell adhesion | 5.706893e-3 |
GO:0006424 | glutamyl-tRNA aminoacylation | 5.706893e-3 |
GO:0032608 | interferon-beta production | 5.706893e-3 |
GO:0007004 | telomere maintenance via telomerase | 5.706893e-3 |
GO:0060586 | multicellular organismal iron ion homeostasis | 5.814041e-3 |
GO:0030046 | parallel actin filament bundle assembly | 5.814041e-3 |
GO:0009994 | oocyte differentiation | 5.826158e-3 |
GO:0043368 | positive T cell selection | 5.863770e-3 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 5.866519e-3 |
GO:0045638 | negative regulation of myeloid cell differentiation | 5.980442e-3 |
GO:0045851 | pH reduction | 6.025800e-3 |
GO:0002253 | activation of immune response | 6.074595e-3 |
GO:0007292 | female gamete generation | 6.121238e-3 |
GO:0050688 | regulation of defense response to virus | 6.133614e-3 |
GO:0032874 | positive regulation of stress-activated MAPK cascade | 6.135608e-3 |
GO:0043278 | response to morphine | 6.196154e-3 |
GO:0006790 | sulfur compound metabolic process | 6.244785e-3 |
GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 6.284533e-3 |
GO:0019752 | carboxylic acid metabolic process | 6.347626e-3 |
GO:0070257 | positive regulation of mucus secretion | 6.364017e-3 |
GO:0003085 | negative regulation of systemic arterial blood pressure | 6.384535e-3 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 6.556811e-3 |
GO:0007183 | SMAD protein complex assembly | 6.584061e-3 |
GO:0015780 | nucleotide-sugar transport | 6.750054e-3 |
GO:0006119 | oxidative phosphorylation | 6.836022e-3 |
GO:0034113 | heterotypic cell-cell adhesion | 6.848206e-3 |
GO:0043403 | skeletal muscle tissue regeneration | 6.890950e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 6.914703e-3 |
GO:0008156 | negative regulation of DNA replication | 6.941731e-3 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 6.957768e-3 |
GO:0002903 | negative regulation of B cell apoptosis | 7.113698e-3 |
GO:0044255 | cellular lipid metabolic process | 7.128584e-3 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 7.157959e-3 |
GO:0070555 | response to interleukin-1 | 7.161159e-3 |
GO:0042180 | cellular ketone metabolic process | 7.267418e-3 |
GO:0016080 | synaptic vesicle targeting | 7.271810e-3 |
GO:0030641 | regulation of cellular pH | 7.409175e-3 |
GO:0033235 | positive regulation of protein sumoylation | 7.422012e-3 |
GO:0005513 | detection of calcium ion | 7.422012e-3 |
GO:0001970 | positive regulation of activation of membrane attack complex | 7.422012e-3 |